Selective properties of C- and N-terminals and core residues of the melanocyte-stimulating hormone on binding to the human melanocortin receptor subtypes

European Journal of Pharmacology

Volumn 349, Issue 2-3, 1998, Pages 359-366

  Schiöth, Helgi B ^a   Mutulis, Felikss ^a,b   Muceniece, Ruta ^a,b   Prusis, Peteris ^a   Wikberg, Jarl E S ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

Author keywords

C terminal; Core residue; Ligand binding; Melanocortin receptor subtype; MSH (melanocyte stimulating hormone

Indexed keywords

ALPHA INTERMEDIN; INTERMEDIN DERIVATIVE; MELANOCORTIN RECEPTOR; RECEPTOR SUBTYPE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ALPHA-MSH; AMINO ACID SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, CORTICOTROPIN; RECEPTORS, MELANOCORTIN; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0344043401     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00212-X     Document Type: Article

References (30)

1. Adan R.A.H., Cone R.D., Burbach J.P.H., Gispen W.H. Differential effects of melanocortin peptides on neural melanocortin receptors. Mol. Pharmacol. 46:1994;1182-1190.
2. 5 receptors. Eur. J. Pharmacol. 269:1994;331-337.
3. Chhajlani V. Distribution of cDNA for melanocortin receptor subtypes in human tissues. Biochem. Mol. Biol. Int. 38:1996;73-80.
4. Chhajlani V., Wikberg J.E.S. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309:1992;417-420.
5. Chhajlani V., Muceniece R., Wikberg J.E.S. Molecular cloning of a novel human melanocortin receptor. Biochem. Biophys. Res. Commun. 195:1993;866-873.
6. Cody W.L., Wilkes B.C., Muska B.J., Hruby V.J., Castrucci A.M. de L., Hadley M.E. Cyclic melanotropins: 5. Importance of the C-terminal tripeptide (Lys-Pro-Val). J. Med. Chem. 27:1984;1186-1190.
7. Cone R.D., Lu D., Koppula S., Vage D.I., Klungland H., Boston B., Chen W., Orth D.N., Pouton C., Kesterson R.A. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog. Horm. Res. 51:1996;287-317.
8. Eberle, A.N., 1988. The Melanotropins: Chemistry, Physiology and Mechanisms of Action. Karger, Basle, pp. 149-319.
9. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:1997;165-168.
10. Fathi Z., Iben L.G., Parker E.M. Cloning, expression, and tissue distribution of a fifth melanocortin receptor subtype. Neurochem. Res. 20:1995;107-113.
11. 7]-alpha-MSH at the melanocortin-1 receptor. Biochem. Biophys. Res. Commun. 202:1994;1266-1271.
12. Gantz I., Konda Y., Tashiro T., Shimoto Y., Miwa H., Munzert G., Watson S.J., Del Valle J., Yamada T. Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 268:1993;8246-8250.
13. Gantz I., Miwa H., Konda Y., Shimoto Y., Tashiro T., Watson S.J., Del Valle J., Yamada T. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J. Biol. Chem. 268:1993;15174-15179.
14. Haskell-Luevano C., Sawyer T.K., Hendrata S., North C., Panahinia L., Stum M., Staples D.J., Castrucci A.M., Hadley M.E., Hruby V.J. Truncation studies of alpha-melanotropin peptides identify tripeptide analogues exhibiting prolonged agonist bioactivity. Peptides. 17:1996;995-1002.
15. Haskell-Luevano C., Hendrata S., North S., Sawyer T.K., Hadley M.E., Hruby V.J., Dickinson C., Gantz I. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R. J. Med. Chem. 40:1997;2133-2139.
16. 2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J. Med. Chem. 38:1995;3454-3461.
17. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., Burn P., Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:1997;131-141.
18. Labbé O., Desarnaud F., Eggerickx D., Vassart G., Parmentier M. Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry. 33:1994;4543-4549.
19. Miwa H., Gantz I., Konda Y., Shimoto Y., Yamada T. Structural determinants of the melanocortin peptides required for activation of melanocortin-3 and melanocortin-4 receptors. J. Pharmacol. Exp. Ther. 273:1995;372-376.
20. Mountjoy K.G., Robbins L.S., Mortrud M.T., Cone R.D. The cloning of a family of genes that encode the melanocortin receptors. Science. 257:1992;1248-1251.
21. Mountjoy K.G., Mortrud M.T., Low M.J., Simerly R.B., Cone R.D. Localization of the melanocortin-4 receptor (MC4-R) in endocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8:1994;1298-1308.
22. 3) receptor from rat hypothalamus: photoaffinity labelling and binding of alanine-substituted α-MSH analogues. FEBS Lett. 350:1994;29-32.
23. Sahm U.G., Olivier G.W., Branch S.K., Moss S.H., Pouton C.W. Synthesis and biological evaluation of α-MSH analogues substituted with alanine. Peptides. 15:1994;1297-1302.
24. 7]α-melanocyte stimulating hormone: a highly potent α-melanotropin with ultralong biological activity. Proc. Natl. Acad. Sci. USA. 77:1980;5754-5758.
25. Schiöth H.B., Muceniece R., Wikberg J.E.S., Chhajlani V. Characterisation of melanocortin receptor subtypes by radioligand binding analysis. Eur. J. Pharmacol. 288:1995;311-317.
26. Schiöth H.B., Muceniece R., Wikberg J.E.S. Characterisation of melanocortin 4 receptor by radioligand binding analysis. Pharmacol. Toxicol. 79:1996;161-165.
27. Schiöth H.B., Chhajlani V., Muceniece R., Klusa V., Wikberg J.E.S. Major pharmacological distinction of the ACTH receptor from the other melanocortic receptors. Life Sci. 59:1996;797-801.
28. Schiöth H.B., Muceniece R., Larsson M., Mutulis F., Szardenings M., Prusis P., Lindeberg G., Wikberg J.E.S. Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes. Eur. J. Pharmacol. 319:1997;369-373.
29. 7] substituted MSH analogues for the melanocortin receptors. Peptides. 18:1997;1009-1013.
30. Schiöth H.B., Muceniece R., Prusis P., Szardenings M., Lindeberg G., Sharma S.D., Hruby V.J., Wikberg J.E.S. Characterisation of D117A and H260A mutations in the melanocortin 1 receptor. Mol. Cell Endocrinol. 126:1997;213-219.